Althea CEO Deborah Simpier explains how “liquid infrastructure” can unlock connectivity for underserved populations around the world.Opinion, opinion, OpinionRead More

You might also be interested in reading Ocugen outlines 2025 milestones for gene therapy programs with BLA filings on track.